Literature DB >> 18768795

Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.

Keiichiro Suzuki1, Kaoru Mitsui, Emi Aizawa, Kouichi Hasegawa, Eihachiro Kawase, Toshiyuki Yamagishi, Yoshihiko Shimizu, Hirofumi Suemori, Norio Nakatsuji, Kohnosuke Mitani.   

Abstract

Human embryonic stem (hES) cells are regarded as a potentially unlimited source of cellular materials for regenerative medicine. For biological studies and clinical applications using primate ES cells, the development of a general strategy to obtain efficient gene delivery and genetic manipulation, especially gene targeting via homologous recombination (HR), would be of paramount importance. However, unlike mouse ES (mES) cells, efficient strategies for transient gene delivery and HR in hES cells have not been established. Here, we report that helper-dependent adenoviral vectors (HDAdVs) were able to transfer genes in hES and cynomolgus monkey (Macaca fasicularis) ES (cES) cells efficiently. Without losing the undifferentiated state of the ES cells, transient gene transfer efficiency was approximately 100%. Using HDAdVs with homology arms, approximately one out of 10 chromosomal integrations of the vector was via HR, whereas the rate was only approximately 1% with other gene delivery methods. Furthermore, in combination with negative selection, approximately 45% of chromosomal integrations of the vector were targeted integrations, indicating that HDAdVs would be a powerful tool for genetic manipulation in hES cells and potentially in other types of human stem cells, such as induced pluripotent stem (iPS) cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768795      PMCID: PMC2544531          DOI: 10.1073/pnas.0806976105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 3.  Progress and problems with the use of viral vectors for gene therapy.

Authors:  Clare E Thomas; Anja Ehrhardt; Mark A Kay
Journal:  Nat Rev Genet       Date:  2003-05       Impact factor: 53.242

4.  Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI.

Authors:  H Suemori; T Tada; R Torii; Y Hosoi; K Kobayashi; H Imahie; Y Kondo; A Iritani; N Nakatsuji
Journal:  Dev Dyn       Date:  2001-10       Impact factor: 3.780

5.  Nucleofection mediates high-efficiency stable gene knockdown and transgene expression in human embryonic stem cells.

Authors:  Kristi A Hohenstein; April D Pyle; Jing Yi Chern; Leslie F Lock; Peter J Donovan
Journal:  Stem Cells       Date:  2008-03-06       Impact factor: 6.277

6.  A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications.

Authors:  Takeharu Nagai; Keiji Ibata; Eun Sun Park; Mie Kubota; Katsuhiko Mikoshiba; Atsushi Miyawaki
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

7.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Authors:  P Yotnda; H Onishi; H E Heslop; D Shayakhmetov; A Lieber; M Brenner; A Davis
Journal:  Gene Ther       Date:  2001-06       Impact factor: 5.250

9.  Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors.

Authors:  Joseph R Smith-Arica; Alison J Thomson; Ray Ansell; John Chiorini; Beverly Davidson; Jim McWhir
Journal:  Cloning Stem Cells       Date:  2003

10.  Homologous recombination in human embryonic stem cells.

Authors:  Thomas P Zwaka; James A Thomson
Journal:  Nat Biotechnol       Date:  2003-02-10       Impact factor: 54.908

View more
  53 in total

Review 1.  Find and replace: editing human genome in pluripotent stem cells.

Authors:  Huize Pan; Weiqi Zhang; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2011-12-15       Impact factor: 14.870

Review 2.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

3.  Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors.

Authors:  Emi Aizawa; Yuka Hirabayashi; Yuzuru Iwanaga; Keiichiro Suzuki; Kenji Sakurai; Miho Shimoji; Kazuhiro Aiba; Tamaki Wada; Norie Tooi; Eihachiro Kawase; Hirofumi Suemori; Norio Nakatsuji; Kohnosuke Mitani
Journal:  Mol Ther       Date:  2011-12-06       Impact factor: 11.454

4.  Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.

Authors:  Kazim H Narsinh; Joseph C Wu
Journal:  Mol Ther       Date:  2010-06       Impact factor: 11.454

5.  BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector.

Authors:  H Yamamoto; M Ishimura; M Ochiai; H Takada; K Kusuhara; Y Nakatsu; T Tsuzuki; K Mitani; T Hara
Journal:  Gene Ther       Date:  2015-08-17       Impact factor: 5.250

Review 6.  Genome editing: a robust technology for human stem cells.

Authors:  Arun Pandian Chandrasekaran; Minjung Song; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

7.  A rapid protocol for construction and production of high-capacity adenoviral vectors.

Authors:  Lorenz Jager; Martin A Hausl; Christina Rauschhuber; Nicola M Wolf; Mark A Kay; Anja Ehrhardt
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 8.  Toward pluripotency by reprogramming: mechanisms and application.

Authors:  Tao Wang; Stephen T Warren; Peng Jin
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

9.  Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.

Authors:  Jizhong Zou; Prashant Mali; Xiaosong Huang; Sarah N Dowey; Linzhao Cheng
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

10.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.